

How Imfinzi Is Transforming Advanced Liver Cancer Treatment
Durvalumab, known commercially as Imfinzi, heralds a new era in advanced liver cancer treatment, particularly for hepatocellular carcinoma. Understanding its clinical efficacy, mechanism of action, administration, side effects, and regulatory journey offers invaluable insight into the evolving cancer treatment landscape and its promise for patients’ futures. Understanding Durvalumab (Imfinzi) as a Treatment for Advanced Liver […]
3 min read